Bio Essence (BIOE) Net Margin Growth (1y) (2021 - 2026)

Bio Essence (BIOE) Net Margin Growth (1y) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (1y) (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 372.00
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -82.00
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -538.00
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -2,930.00
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 2,292.00
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -146.00
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -2,359.00
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 1,181.00
10 Bio Essence - - 319,353.00 96,830.00

Historic Data

Download Data
DateValue
Mar 31, 2026 96,830.00
Sep 30, 2025 9,921.00
Mar 31, 2025 -117,278.00
Sep 30, 2024 31,694.00
Mar 31, 2024 19,311.00
Dec 31, 2023 -17,514.00
Sep 30, 2023 -51,038.00
Jun 30, 2023 5,262.00
Mar 31, 2023 -2,369.00
Dec 31, 2022 -17,170.00
Sep 30, 2022 2,310.00
Jun 30, 2022 -1,233.00
Mar 31, 2022 17,529.00
Dec 31, 2021 8,344.00
Sep 30, 2021 17,029.00
Jun 30, 2021 15,925.00
Mar 31, 2021 -6,097.00